{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T06:14:07Z","timestamp":1788502447869,"version":"build-2803163510"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>This study evaluated the impact of structured clinical pharmacist-led counseling on hospital admissions due to chemotherapy side effects, patient satisfaction, and cost avoidance in patients receiving intravenous chemotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      A prospective pre\u2013post quality improvement study was conducted at a tertiary care center in Saudi Arabia. The preintervention cohort (October 2024\u2013February 2025,\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 118) received standard care; the postintervention cohort (April\u2013August 2025,\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 135) received structured 30-min pharmacist-led counseling covering regimen-specific education, anticipatory guidance on toxicity, self-management strategies, red-flag symptom recognition, and monitoring protocols. The primary outcome was the hospital admission rate due to chemotherapy-related side effects. Secondary outcomes included side effect-specific admissions, patient satisfaction, and economic impact.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings:<\/jats:title>\n                    <jats:p>\n                      The intervention achieved a 34.4% relative reduction in admission rates (13.56%\u20138.89%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.02; number needed to treat = 22). Complete elimination of admissions for gastrointestinal toxicities and 38.8% reduction in febrile neutropenia admissions were observed. Patient satisfaction reached 94.4%, with 97.2% service coverage. Net cost savings totaled $38,850 over 5 months (ROI: 747%), with febrile neutropenia prevention accounting for 76.6% of savings.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Structured pharmacist-led counseling significantly reduced chemotherapy-related hospital admissions, achieved exceptional patient satisfaction, and demonstrated strong economic value, supporting its integration as standard supportive care in oncology practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jrpp.jrpp_24_26","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T06:00:08Z","timestamp":1788501608000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacist-led Chemotherapy Counseling: Impact on Hospital Admissions, Patient Satisfaction, and Cost Avoidance \u2013 A Prospective Pre\u2013post Quality Improvement Study"],"prefix":"10.4103","volume":"15","author":[{"given":"Abdulmohsen","family":"Assiri","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, Armed Forces Hospital Southern Region, Khamis Mushait, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isra Abu","family":"Median","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Armed Forces Hospital Southern Region, Khamis Mushait, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Alshahrani","sequence":"additional","affiliation":[{"name":"Pharmaceutical Care Administration, Armed Forces Hospital Southern Region, Khamis Mushait, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Asiri","sequence":"additional","affiliation":[{"name":"Pharmaceutical Care Administration, Armed Forces Hospital Southern Region, Khamis Mushait, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama","family":"Alsaeed","sequence":"additional","affiliation":[{"name":"Pharmaceutical Care Administration, Armed Forces Hospital Southern Region, Khamis Mushait, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Asiri","sequence":"additional","affiliation":[{"name":"Pharmaceutical Care Administration, Armed Forces Hospital Southern Region, Khamis Mushait, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Abashar","sequence":"additional","affiliation":[{"name":"Pharmaceutical Care Administration, Armed Forces Hospital Southern Region, Khamis Mushait, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Basic Sciences, College of Medicine, Sulaiman Alrajhi University, Albukayriyah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aseel","family":"Alsraeya","sequence":"additional","affiliation":[{"name":"Pharmaceutical Care Administration, Armed Forces Hospital Southern Region, Khamis Mushait, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8]]},"reference":[{"key":"R1-20260904","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1186\/s13063-015-0970-0","article-title":"The patient remote intervention and symptom management system (PRISMS) \u2013 A telehealth- mediated intervention enabling real-time monitoring of chemotherapy side-effects in patients with haematological malignancies: Study protocol for a randomised controlled trial","volume":"16","author":"Breen","year":"2015","journal-title":"Trials"},{"key":"R2-20260904","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1186\/s12885-019-6099-x","article-title":"Ambulatory toxicity management (AToM) in patients receiving adjuvant or neo-adjuvant chemotherapy for early stage breast cancer \u2013 A pragmatic cluster randomized trial protocol","volume":"19","author":"Krzyzanowska","year":"2019","journal-title":"BMC Cancer"},{"key":"R3-20260904","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1634\/theoncologist.7-3-179","article-title":"Does economics matter when treating advanced non-small cell lung cancer?","volume":"7","author":"Ramsey","year":"2002","journal-title":"Oncologist"},{"key":"R4-20260904","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hsdr03140","article-title":"The delivery of chemotherapy at home: An evidence synthesis","volume":"3","author":"Corbett","year":"2015","journal-title":"Health Serv Deliv Res"},{"key":"R5-20260904","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1177\/1078155220976801","article-title":"Impact of clinical pharmacy in oncology and hematology centers: A systematic review","volume":"27","author":"Oliveira","year":"2020","journal-title":"J Oncol Pharm Pract"},{"key":"R6-20260904","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/jcpt.12562","article-title":"The effects of pharmacist interventions on adult outpatients with cancer: A systematic review","volume":"42","author":"Colombo","year":"2017","journal-title":"J Clin Pharm Ther"},{"key":"R7-20260904","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1093\/ajhp\/zxae237","article-title":"Impact of oncology pharmacy services on the management of chemotherapy-induced nausea and vomiting: A systematic review and meta-analysis","volume":"82","author":"Shin","year":"2024","journal-title":"Am J Health Syst Pharm"},{"key":"R8-20260904","doi-asserted-by":"crossref","first-page":"166","DOI":"10.31351\/vol33iss4pp166-173","article-title":"Impact of clinical pharmacist led interventions on short term quality of life among breast cancer women taking chemotherapy","volume":"33","author":"Alkashaf","year":"2024","journal-title":"Iraqi J Pharm Sci"},{"key":"R9-20260904","first-page":"502431","article-title":"Impact of clinical pharmacy services on KAP and QOL in cancer patients: A single-center experience","author":"Wang","year":"2015","journal-title":"Biomed Res Int 2015"},{"key":"R10-20260904","first-page":"6505","article-title":"Implementation and outcomes of a pharmacist-led collaborative drug therapy management program for oncology symptom management","volume":"29","author":"Homan","year":"2021","journal-title":"Support Care Cancer"},{"key":"R11-20260904","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12955-017-0680-2","article-title":"Effect of chemotherapy counseling by pharmacists on quality of life and psychological outcomes of oncology patients in Malaysia: A randomized control trial","volume":"15","author":"Periasamy","year":"2017","journal-title":"Health Qual Life Outcomes"},{"key":"R12-20260904","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40780-022-00239-w","article-title":"Pharmaceutical intervention for adverse events improves quality of life in patients with cancer undergoing outpatient chemotherapy","volume":"8","author":"Fujii","year":"2022","journal-title":"J Pharm Health Care Sci"},{"key":"R13-20260904","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1200\/JOP.17.00039","article-title":"Improved adherence rates and clinical outcomes of an integrated, closed-loop, pharmacist-led oral chemotherapy management program","volume":"14","author":"Muluneh","year":"2018","journal-title":"J Oncol Pract"},{"key":"R14-20260904","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1177\/10781552231202221","article-title":"Clinical and economic impact of oncology trained pharmacist integration in an ambulatory cancer clinic","volume":"30","author":"Mull","year":"2024","journal-title":"J Oncol Pharm Pract"},{"key":"R15-20260904","doi-asserted-by":"crossref","first-page":"e1303","DOI":"10.1200\/OP.20.00639","article-title":"Chemotherapy remote care monitoring program: Integration of SMS text patient-reported outcomes in the electronic health record and pharmacist intervention for chemotherapy-induced nausea and vomiting","volume":"17","author":"Hough","year":"2021","journal-title":"JCO Oncol Pract"},{"key":"R16-20260904","doi-asserted-by":"crossref","first-page":"439","DOI":"10.31083\/ph.2019.9327","article-title":"Cost utility analysis of pharmacist counseling care for breast cancer chemotherapy outpatients","volume":"74","author":"Tanaka","year":"2019","journal-title":"Pharmazie"},{"issue":"(Suppl 1)","key":"R17-20260904","first-page":"005","article-title":"Implementing medication reconciliation on hospital admission: A multicentre pilot study in Estonia and Finland","volume":"27","author":"Randm\u00e4e","year":"2020","journal-title":"Eur J Hosp Pharm"},{"key":"R18-20260904","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1200\/JCO.20.03088","article-title":"The randomized AMBORA trial: Impact of pharmacological\/pharmaceutical care on medication safety and patient-reported outcomes during treatment with new oral anticancer agents","volume":"39","author":"D\u00fcrr","year":"2021","journal-title":"J Clin Oncol"},{"key":"R19-20260904","doi-asserted-by":"crossref","first-page":"e35865","DOI":"10.2196\/35865","article-title":"The pharmacoeconomic impact of pharmaceutical care in the hospital: Protocol for an overview of systematic reviews","volume":"12","author":"Amorim","year":"2023","journal-title":"JMIR Res Protoc"},{"key":"R20-20260904","first-page":"373","article-title":"Chemotherapy induced febrile neutropenia (FN): Healthcare resource utilization (HCRU) and costs in commercially insured patients in the US","volume":"32","author":"Flanigan","year":"2024","journal-title":"Support Care Cancer"},{"key":"R21-20260904","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3111\/13696998.2013.782034","article-title":"A retrospective study of the clinical and economic burden during hospitalizations among cancer patients with febrile neutropenia","volume":"16","author":"Dulisse","year":"2013","journal-title":"J Med Econ"},{"key":"R22-20260904","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1038\/s41598-021-86911-x","article-title":"Hospitalization rates for complications due to systemic therapy in the United States","volume":"11","author":"Saxena","year":"2021","journal-title":"Sci Rep"},{"key":"R23-20260904","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1093\/annonc\/mdr520","article-title":"Epidemiology, management and economic impact of febrile neutropenia in oncology patients receiving routine care at a regional UK cancer centre","volume":"23","author":"Schelenz","year":"2012","journal-title":"Ann Oncol"}],"container-title":["Journal of Research in Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jrpp.jrpp_24_26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T06:00:11Z","timestamp":1788501611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jrpp.jrpp_24_26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jrpp.jrpp_24_26","relation":{},"ISSN":["2319-9644","2279-042X"],"issn-type":[{"value":"2319-9644","type":"print"},{"value":"2279-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"2026-03-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}